Callan JMB Inc. (NASDAQ:CJMB) Sees Significant Increase in Short Interest

Callan JMB Inc. (NASDAQ:CJMB) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 329,344 shares, a growth of 273.6% from the May 31st total of 88,152 shares. Currently, 22.3% of the company’s stock are sold short. Based on an average daily trading volume, of 557,370 shares, the days-to-cover ratio is currently 0.6 days.

Institutional Trading of Callan JMB

An institutional investor recently raised its position in Callan JMB stock. Creative Planning lifted its holdings in Callan JMB Inc. (NASDAQ:CJMB) by 41.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 170,008 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Creative Planning owned 3.79% of Callan JMB worth $830,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Callan JMB Stock Down 1.3%

Shares of NASDAQ CJMB traded down $0.01 during trading on Friday, reaching $0.76. The company had a trading volume of 67,123 shares, compared to its average volume of 332,599. Callan JMB has a 12-month low of $0.65 and a 12-month high of $5.88. The business’s 50-day moving average is $0.89 and its 200 day moving average is $1.41. The stock has a market cap of $4.29 million, a PE ratio of -0.37 and a beta of -0.07.

Callan JMB (NASDAQ:CJMB) last issued its earnings results on Friday, May 15th. The company reported ($0.59) earnings per share (EPS) for the quarter. Callan JMB had a negative return on equity of 285.36% and a negative net margin of 184.70%.The firm had revenue of $1.11 million during the quarter.

Analyst Ratings Changes

A number of analysts have recently commented on CJMB shares. Weiss Ratings restated a “sell (e+)” rating on shares of Callan JMB in a report on Wednesday, April 29th. Wall Street Zen raised shares of Callan JMB to a “hold” rating in a research report on Saturday, March 28th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Callan JMB currently has a consensus rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.